Tzu Chi Medical Journal
Volume 20, Issue 4 , Pages 275-279 , December 2008

Association of Insulin Resistance with Alanine Aminotransferase Activity in Patients with Nonalcoholic Fatty Liver Disease

  • Chia-Chi Wang

      Affiliations

    • Department of Gastroenterology, Buddhist Tzu Chi General Hospital, Taipei Branch, Taipei, Taiwan
  • ,
  • Wai-Wah Wu

      Affiliations

    • Department of Gastroenterology, Buddhist Tzu Chi General Hospital, Taipei Branch, Taipei, Taiwan
  • ,
  • Ching-Sheng Hsu

      Affiliations

    • Department of Gastroenterology, Buddhist Tzu Chi General Hospital, Taipei Branch, Taipei, Taiwan
  • ,
  • Pin-Chao Wang

      Affiliations

    • Department of Gastroenterology, Buddhist Tzu Chi General Hospital, Taipei Branch, Taipei, Taiwan
  • ,
  • Hans Hsienhong Lin

      Affiliations

    • Department of Gastroenterology, Buddhist Tzu Chi General Hospital, Taipei Branch, Taipei, Taiwan
  • ,
  • Jia-Horng Kao

      Affiliations

    • Department of Internal Medicine, Hepatic Research Center and Department of Medical Research, National Taiwan University College of Medicine and National Taiwan University Hospital, Taipei, Taiwan
    • Corresponding Author InformationCorresponding author. Department of Internal Medicine, Hepatic Research Center and Department of Medical Research, National Taiwan University College of Medicine and National Taiwan University Hospital, 7, Chung-Shan South Road, Taipei, Taiwan

Received 20 February 2008 ,Revised 27 March 2008 ,Accepted 5 May 2008.

References 

  1. Chitturi S , Farrell GC , George J . Non-alcoholic steatohepatitis in the Asia-Pacific region: future shock? . J Gastroenterol Hepatol . 2004;19:368–374
  2. Matteoni CA , Younossi ZM , Gramlich T , Boparai N , Liu YC , McCullough AJ . Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity . Gastroenterology . 1999;116:1413–1419
  3. Marchesini G , Brizi M , Bianchi G , et al.   Nonalcoholic fatty liver disease: a feature of the metabolic syndrome . Diabetes . 2001;50:1844–1850
  4. Marchesini G , Bugianesi E , Forlani G , et al.   Non-alcoholic fatty liver, steatohepatitis and the metabolic syndrome . Hepatology . 2003;37:917–923
  5. Clark JM , Diehl AM . Hepatic steatosis and type 2 diabetes mellitus . Curr Diab Rep . 2002;2:210–215
  6. Brea A , Mosquera D , Martin E , Arizti A , Cordero JL , Ros E . Nonalcoholic fatty liver disease is associated with carotid atherosclerosis: a case-control study . Arterioscler Thromb Vasc Biol . 2005;25:1045–1050
  7. Day CP , James OF . Steatohepatitis: a tale of two “hits”? . Gastroenterology . 1998;114:842–845
  8. Scheig R . Evaluation of tests used to screen patients with liver disorders . Prim Care . 1996;23:551–560
  9. Hanley AJ , Williams K , Festa A , et al.   Elevations in markers of liver injury and risk of type 2 diabetes: the insulin resistance atherosclerosis study . Diabetes . 2004;53:2623–2632
  10. Hanley AJ , Williams K , Festa A , Wagenknecht LE , D'Agostino RB Jr , Haffner SM . Liver markers and development of the metabolic syndrome: the insulin resistance atherosclerosis study . Diabetes . 2005;54:3140–3147
  11. Farrell GC , Chitturi S , Lau GK , Sollano JD; Asia-Pacific Working Party on NAFLD . Guideline for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region: executive summary . J Gastroenterol Hepatol . 2007;22:775–777
  12. Bonora E , Targher G , Alberiche M , et al.   Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity . Diabetes Care . 2000;23:57–63
  13. Prati D , Taioli E , Zanella A , et al.   Updated definitions of healthy ranges for serum alanine aminotransferase levels . Ann Intern Med . 2002;137:1–10
  14. Osawa H , Mori Y . Sonographic diagnosis of fatty liver using a histogram technique that compares liver and renal cortical amplitudes . J Clin Ultrasound . 1986;24:25–29
  15. Saadeh S , Younossi ZM , Remer EM , et al.   The utility of radiographic imaging in nonalcoholic fatty liver disease . Gastroenterology . 2002;123:745–750
  16. Marchesini G , Avagnina S , Barantani EG , et al.   Aminotransferase and gamma-glutamyltranspeptidase levels in obesity are associated with insulin resistance and the metabolic syndrome . J Endocrinol Invest . 2005;28:333–339
  17. Chung RT , Casson DR , Murray G , Song S , Grinspoon S , Hadigan C . Alanine aminotransferase levels predict insulin resistance in HIV lipodystrophy . J Acquir Immune Defic Syndr . 2003;34:534–536
  18. de Luis DA , Aller R , Izaola O , Sagrado MG , Con de R , Bellido D . Influence of insulin resistance and adipocytokines on elevated serum aminotransferase in obese patients . Arch Med Res . 2008;39:110–114
  19. Dessein PH , Woodiwiss AJ , Joffe BI , Norton GR . Aminotransferases are associated with insulin resistance and atherosclerosis in rheumatoid arthritis. BMC Cardiovasc Disord 2007;7:31. 20. Shen YH, Yang WS, Lee TH, Lee LT, Chen CY, Huang KC. Bright liver and alanine aminotransferase are associated with metabolic syndrome in adults . Obes Res . 2005;13:1238–1245
  20. Belfort R , Harrison SA , Brown K , et al.   A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis . N Engl J Med . 2006;355:2297–2307
  21. Sheth SG , Gordon FD , Chopra S . Nonalcoholic steatohepatitis . Ann Intern Med . 1997;126:137–145
  22. Su CC , Wang K , Hsia TL , Chen CS , Tung TH . Association of nonalcoholic fatty liver disease with abnormal aminotransferase and postprandial hyperglycemia . J Clin Gastroenterol . 2006;40:551–554
  23. Hanley AJ , Wagenknecht LE , Festa A , D'Agostino RB Jr , Haffner SM . Alanine aminotransferase and directly measured insulin sensitivity in a multiethnic cohort: the Insulin Resistance Atherosclerosis Study . Diabetes Care . 2007;30:1819–1827
  24. Schindhelm RK , Dekker JM , Nijpels G , et al.   Alanine aminotransferase predicts coronary heart disease events: a 10-year follow-up of the Hoorn Study . Atherosclerosis . 2007;191:391–396
  25. Chen CH , Huang MH , Yang JC , et al.   Prevalence and risk factors of nonalcoholic fatty liver disease in an adult population of Taiwan: metabolic significance of nonalcoholic fatty liver disease in nonobese adults . J Clin Gastroenterol . 2006;40:745–752
  26. The IDF Consensus Worldwide Definition of the Metabolic Syndrome . International Diabetes Federation; 2006;
  27. Oh SY , Cho YK , Kang MS , et al.   The association between increased alanine aminotransferase activity and metabolic factors in nonalcoholic fatty liver disease . Metabolism . 2006;55:1604–1609
  28. Salazar MR , Carbajal HA , Curciarello JO , Aizpurua M , Adrover RE , Riondet B . Alanine-aminotransferase: an early marker for insulin resistance? . Medicina (B Aires) . 2007;67:125–130
  29. Fraser A , Ebrahim S , Smith GD , Lawlor DA . A comparison of association of alanine aminotransferase and gammaglutamyltransferase with fasting glucose, fasting insulin, and glycated hemoglobin in women with and without diabetes . Hepatology . 2007;46:158–165
  30. Mittendorfer B . Insulin resistance: sex matter . Curr Opin Clin Nutr Metab Care . 2005;8:367–372

PII: S1016-3190(08)60050-6

doi: 10.1016/S1016-3190(08)60050-6

Tzu Chi Medical Journal
Volume 20, Issue 4 , Pages 275-279 , December 2008